Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)
| Status: | Completed |
|---|---|
| Conditions: | Cognitive Studies, Cognitive Studies, Neurology |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 3/22/2019 |
| Start Date: | January 2015 |
| End Date: | July 2016 |
The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive
assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia.
SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable
forms allows it to be given in almost any setting, does not require any staff time to
administer and makes it practical to rapidly screen large numbers of individuals in the
community or in their home.This trial is being conducted to study the validity of SAGE in a
digital format (eSAGE) for cognitive screening.
The investigators will analyze the data to learn the correlations between eSAGE and gold
standard neuropsychological testing designed to differentiate normal cognition from MCI and
early dementia. The investigators will also find out whether the paper (SAGE) and electronic
(eSAGE) versions of SAGE could be used interchangeably or not.
assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia.
SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable
forms allows it to be given in almost any setting, does not require any staff time to
administer and makes it practical to rapidly screen large numbers of individuals in the
community or in their home.This trial is being conducted to study the validity of SAGE in a
digital format (eSAGE) for cognitive screening.
The investigators will analyze the data to learn the correlations between eSAGE and gold
standard neuropsychological testing designed to differentiate normal cognition from MCI and
early dementia. The investigators will also find out whether the paper (SAGE) and electronic
(eSAGE) versions of SAGE could be used interchangeably or not.
Participants will be recruited based on their eSAGE scores and evaluated with
neuropsychological testing and medical history to determine their status as normal, mild
cognitive impairment, or dementia.
The investigators will analyze the data to learn the correlations between eSAGE and gold
standard neuropsychological testing designed to differentiate normal cognition from MCI and
early dementia. The investigators will also find out whether the paper (SAGE) and electronic
(eSAGE) versions of SAGE could be used interchangeably or not.
neuropsychological testing and medical history to determine their status as normal, mild
cognitive impairment, or dementia.
The investigators will analyze the data to learn the correlations between eSAGE and gold
standard neuropsychological testing designed to differentiate normal cognition from MCI and
early dementia. The investigators will also find out whether the paper (SAGE) and electronic
(eSAGE) versions of SAGE could be used interchangeably or not.
Inclusion Criteria:
- Adults over 49 years old of either gender
- Vision and hearing sufficient for compliance with tests
Exclusion Criteria:
- Diagnosis by a physician of moderate or severe dementia
- Intellectual disability
We found this trial at
1
site
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
Click here to add this to my saved trials
